Aquestive Therapeutics, Inc. AQST Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s accrued liabilities, current?
- Aquestive Therapeutics, Inc. (AQST) reported accrued liabilities, current of $3.45M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Aquestive Therapeutics, Inc.'s accrued liabilities, current increased by 4.1% year-over-year, from $3.31M to $3.45M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s accrued liabilities, current has grown at a -10.1% compound annual growth rate (CAGR), from $8.57M to $5.03M.